The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1.
about
In vitro nuclear interactome of the HIV-1 Tat proteinThe bovine herpesvirus 1 immediate-early protein (bICP0) associates with histone deacetylase 1 to activate transcription.Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencingTranscriptional repression of human immunodeficiency virus type 1 by AP-4The SWI/SNF chromatin-remodeling complex is a cofactor for Tat transactivation of the HIV promoterCounterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator TatExpression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acidThe transcription factor LSF: a novel oncogene for hepatocellular carcinomaRegulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoterYY1 and FoxD3 regulate antiretroviral zinc finger protein OTK18 promoter activation induced by HIV-1 infectionSIRT1 regulates HIV transcription via Tat deacetylationImpact of Chromatin on HIV ReplicationPost-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virusBromodomain proteins in HIV infectionRecent developments in human immunodeficiency virus-1 latency researchChromatin, non-coding RNAs, and the expression of HIVDepletion of latent HIV-1 infection in vivo: a proof-of-concept studyTargeted derepression of the human immunodeficiency virus type 1 long terminal repeat by pyrrole-imidazole polyamides.Oncogenic potential of yin yang 1 mediated through control of imprinted genesEpigenetic regulation of HIV-1 latency by cytosine methylationInduction of the transcriptional repressor Yin Yang-1 by vascular cell injury. Autocrine/paracrine role of endogenous fibroblast growth factor-2Latency reversal and viral clearance to cure HIV-1.Eradication therapies for HIV Infection: time to begin again.Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells.Control of stochastic gene expression by host factors at the HIV promoter.Yeast genetic analysis reveals the involvement of chromatin reassembly factors in repressing HIV-1 basal transcriptionTranscriptional Gene Silencing (TGS) via the RNAi Machinery in HIV-1 InfectionsMechanisms of HIV Transcriptional Regulation by Drugs of Abuse.Combinatorial latency reactivation for HIV-1 subtypes and variantsInvolvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294.Erythroid cell-specific alpha-globin gene regulation by the CP2 transcription factor family.Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation.BET bromodomain inhibition as a novel strategy for reactivation of HIV-1Repressive LTR nucleosome positioning by the BAF complex is required for HIV latency.HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostatA flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs.Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.LSF expression and its prognostic implication in colorectal cancerSelective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaBA prospective on drug abuse-associated epigenetics and HIV-1 replication.
P2860
Q21245051-3860AC24-1733-46F3-A2B1-892358567F1BQ24291697-0E2005C8-8BAD-4C24-AA08-7AC3946256BDQ24294385-C728A0BF-7A0A-4391-8FE3-C4E475505803Q24307916-3F9D0EE4-080A-4A6B-A178-3AC44BA19E04Q24336893-CEB03A08-5287-4939-9D46-13AF0DCAD440Q24537275-18D24510-8D10-4176-BC34-91B75D8B4884Q24596282-724F1706-9FF3-407F-BEEE-0C44216FCF08Q24613885-10DAAF43-BA63-49C2-AAEF-529F5F69F7C3Q24634457-19C05D5C-99D5-4A0C-BC77-5BFADD987A75Q24646624-3FB64D7D-1883-4AB3-8D42-8A1D227653BDQ24797263-1C8747B0-24B8-48EB-9DE6-441DBFBB805CQ26782046-AEC425A6-9FA8-4EA8-B6CB-0B972BAC01FFQ26797870-90C53338-3BE1-41CC-92F4-AF13B31D9E73Q26829860-0FD27D81-E245-4DAE-B3EB-A375B8497D6AQ27013114-147AAABD-FE13-4D28-B8AD-69870B43CDE4Q27021127-80FD8A2A-0C9F-4188-AC70-DC86A1F07828Q28111910-9E116063-A341-4E6D-A99C-64C42E0E71D0Q28213125-9A268346-67CA-4E07-ACAD-EAC7BDE3B477Q28257555-08CF5D85-387F-45B6-B1EE-118FD233F6CCQ28475636-44DA9E24-1443-4E2C-A4B6-02F8AF505C3CQ28581596-A507484B-4564-48C7-950E-2973EE1A28F2Q30248766-FA23A476-D47C-49E5-8A91-3D4CA3991A35Q30399588-E1B72A54-1951-412E-8452-9D61FBA7D590Q33250088-5CF3D918-710F-41CB-A167-0C3B4A1459DFQ33398516-8DA5385C-F8C5-4361-B725-2870A70ED387Q33400343-A7C711C6-3887-472E-BD24-C7EA70105C32Q33565167-614357DF-6827-4CFF-A257-E5FF23A0F0CCQ33815611-5B41FB50-EBAA-4819-98B4-397D5F64AC71Q33877492-882FD9F5-52DA-4EF0-A044-8C090899CAF5Q33883423-493A42E1-1B3F-4AAD-9F54-EB3D37863BCDQ33884209-CEAF53A7-3774-4925-9FB8-C00DB8CE5E4EQ34012255-102B68B4-AB4E-451A-BDA0-8263A9E684C4Q34032827-EA7DB69A-7988-491A-B6D1-87479286CC3DQ34090863-ACA94681-1797-47B7-AD9A-4D346A41EBFCQ34106191-2AF92306-5B9E-4C63-B33E-2A56829A4C71Q34145909-E8812731-212D-4360-8631-8E1C7FAD0F06Q34349201-236FFE02-C3FA-4EE8-B4BD-5969F09D2B3DQ34371544-1F0DC7FF-161E-4874-B1FC-A24632EBD696Q34482017-4546DDFB-1E6A-4E50-8417-73ADCDC4B1E5Q34612737-EFDA7D88-29B0-47CA-898C-DA845C784910
P2860
The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The human factors YY1 and LSF ...... tment of histone deacetylase 1
@nl
The human factors YY1 and LSF ...... ment of histone deacetylase 1.
@ast
The human factors YY1 and LSF ...... ment of histone deacetylase 1.
@en
The human factors YY1 and LSF ...... ment of histone deacetylase 1.
@en-gb
type
label
The human factors YY1 and LSF ...... tment of histone deacetylase 1
@nl
The human factors YY1 and LSF ...... ment of histone deacetylase 1.
@ast
The human factors YY1 and LSF ...... ment of histone deacetylase 1.
@en
The human factors YY1 and LSF ...... ment of histone deacetylase 1.
@en-gb
prefLabel
The human factors YY1 and LSF ...... tment of histone deacetylase 1
@nl
The human factors YY1 and LSF ...... ment of histone deacetylase 1.
@ast
The human factors YY1 and LSF ...... ment of histone deacetylase 1.
@en
The human factors YY1 and LSF ...... ment of histone deacetylase 1.
@en-gb
P2093
P2860
P3181
P1433
P1476
The human factors YY1 and LSF ...... ment of histone deacetylase 1.
@en
P2093
D M Margolis
J L Volker
K M Galvin
P2860
P304
P3181
P356
10.1128/JVI.74.15.6790-6799.2000
P407
P577
2000-08-01T00:00:00Z